CAMBRIDGE, Mass., March 2, 2021 /PRNewswire/ -- Akebia
Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company
with the purpose to better the lives of people impacted by kidney
disease, today announced that John P.
Butler, Chief Executive Officer of Akebia, will participate
in a fireside chat at the H.C. Wainwright Global Life Sciences
Conference, which takes place virtually March 9-10, 2021.
The recorded presentation will be available on the Investors
section of the Company's website at
https://ir.akebia.com beginning Tuesday, March 9.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is
a fully integrated biopharmaceutical company with the purpose to
better the lives of people impacted by kidney disease. The Company
was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more
information, please visit our website at www.akebia.com, which does
not form a part of this release.
Akebia Therapeutics Contact
Kristen K. Sheppard, Esq.
ir@akebia.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-hc-wainwright-global-life-sciences-conference-301237797.html
SOURCE Akebia Therapeutics